Vaylenx is run by CEO Noah Rosenblatt, CFO David Bartizal, COO Morgan Stanely, and CCO Kate Clausen. Their product, CNP-1, is an environmentally friendly, affordable, effective solution to mosquito spread diseases that claim over 1 million lives every year.
At TCU, Vaylenx was recognized with the Founder’s Award which recognizes the most inspirational project with the largest impact. We cannot wait to see what they do in the future. Read the full story here!